Ayunan, Fatresia .
HRN: 26-98-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/16/2025
04/22/2025
0RAL
11ml
TID
AGE
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes